| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $3.3M | — | +100.9% |
| SG&A Expense | $4.3M | — | +24.6% |
| Operating Income | -$7.7M | — | -49.3% |
| Pre-tax Income | -$6.3M | — | -33.0% |
| Income Tax | $0 | — | — |
| Net Income | -$6.3M | — | -33.0% |
| EPS (Diluted) | -$0.20 | — | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $217.1M | +7.2% | +277.8% |
| Total Assets | $218.9M | +7.4% | +275.6% |
| Current Liabilities | $1.3M | +52.4% | +33.7% |
| Stockholders' Equity | $217.6M | +7.2% | +279.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.8M | — | -44.6% |
| Investing Cash Flow | -$8K | — | — |
| Financing Cash Flow | $18.6M | — | -8.2% |